Cellular models for the evaluation of the antiobesity effect of selected phytochemicals from food and herbs

Journal of Food and Drug Analysis

Volumn 25, Issue 1, 2017, Pages 100-110

  Tung, Yen Chen ^a   Hsieh, Pei Hsuan ^b   Pan, Min Hsiung ^a,c,d   Ho, Chi Tang ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b RUTGERS UNIVERSITY   (United States)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

3T3 L1 cells; adipogenesis; lipogenesis; lipolysis; phytochemicals

Indexed keywords

ANTIOBESITY AGENT; HORMONE; PLANT MEDICINAL PRODUCT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCOUPLING PROTEIN; PLANT EXTRACT;

ADIPOGENESIS; ANIMAL CELL; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; DIETARY INTAKE; FATTY ACID OXIDATION; FOOD; HERB; HORMONE BLOOD LEVEL; IN VITRO STUDY; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MOUSE; NONHUMAN; OBESITY; PLANT BROWNING; PLANT CELL; PROADIPOCYTE; PROTEIN EXPRESSION; RAT; REVIEW; THERMOGENESIS; WHITE ADIPOSE TISSUE; ANIMAL; HUMAN; MEDICINAL PLANT;

ADIPOGENESIS; ANIMALS; FOOD; HUMANS; LIPID METABOLISM; OBESITY; PHYTOCHEMICALS; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 85008168825     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2016.10.018     Document Type: Review

References (103)

1. [1] WHO, Global health risks: mortality and burden of disease attributable to selected major risks. 2009, World Health Organization.
2. [2] Torres-Fuentes, C., Schellekens, H., Dinan, T.G., Cryan, J.F., A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review. Nutr Neurosci 18 (2015), 49–65.
3. [3] Lee, K.H., Current developments in the discovery and design of new drug candidates from plant natural product leads. J Nat Prod 67 (2004), 273–283.
4. [4] Cragg, G.M., Newman, D.J., Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830 (2013), 3670–3695.
5. [5] Moerman, D.E., Medicinal plants of native America. 1986, Museum of Anthropology, University of Michigan, Ann Arbor.
6. [6] Santos, Ana Paula, Rogero, Marcelo M., Bastos, Deborah H.M., Edible plants, their secondary metabolites and antiobesogenic potential. Recent Pat Food Nutr Agric 2 (2010), 195–212.
7. [7] Unger, R.H., Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144 (2003), 5159–5165.
8. [8] Dizdar, Ö., Alyamaç, E., Obesity: an endocrine tumor?. Med Hypotheses 63 (2004), 790–792.
9. [9] Ka, S.O., Kim, K.A., Kwon, K.B., Park, J.W., Park, B.H., Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway. Int J Mol Med, 23, 2009, 633.
10. [10] Kersten, S., Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2 (2001), 282–286.
11. [11] Sarjeant, K., Stephens, J.M., Adipogenesis. Cold Spring Harb Perspect Biol, 4, 2012, a008417.
12. [12] Geloen, A., Roy, P.E., Bukowiecki, L.J., Regression of white adipose tissue in diabetic rats. Am J Physiol 257 (1989), E547–E553.
13. [13] Ali, A.T., Hochfeld, W.E., Myburgh, R., Pepper, M.S., Adipocyte and adipogenesis. Eur J Cell Biol 92 (2013), 229–236.
14. [14] Symonds, M.E., (eds.) Adipose tissue biology, 2011, Springer-Verlag, New York.
15. [15] Cannon, B., Nedergaard, J., Brown adipose tissue: function and physiological significance. Physiol Rev 84 (2004), 277–359.
16. [16] Farmer, S.R., Molecular determinants of brown adipocyte formation and function. Genes Dev 22 (2008), 1269–1275.
17. [17] Armani, A., Mammi, C., Marzolla, V., Calanchini, M., Antelmi, A., Rosano, G., Fabbri, A., Caprio, M., Cellular models for understanding adipogenesis, adipose dysfunction, and obesity. J Cell Biochem 110 (2010), 564–572.
18. [18] Gregoire, F.M., Smas, C.M., Sul, H.S., Understanding adipocyte differentiation. Physiol Rev 78 (1998), 783–809.
19. [19] Ntambi, J.M., Young-Cheul, K., Adipocyte differentiation and gene expression. J Nutr 130 (2000), 3122S–3126S.
20. [20] Green, H., Meuth, M., An established pre-adipose cell line and its differentiation in culture. Cell 3 (1974), 127–133.
21. [21] Poulos, S.P., Dodson, M.V., Hausman, G.J., Cell line models for differentiation: preadipocytes and adipocytes. Exp Biol Med (Maywood) 235 (2010), 1185–1193.
22. [22] Green, H., Kehinde, O., An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell 5 (1975), 19–27.
23. [23] Kuri-Harcuch, W., Green, H., Increasing activity of enzymes on pathway of triacylglycerol synthesis during adipose conversion of 3T3 cells. J Biol Chem 252 (1977), 2158–2160.
24. [24] Cornelius, P., MacDougald, O.A., Lane, M.D., Regulation of adipocyte development. Annu Rev Nutr 14 (1994), 99–129.
25. [25] Rubin, C.S., Hirsch, A., Fung, C., Rosen, O.M., Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells. J Biol Chem 253 (1978), 7570–7578.
26. [26] Smith, P.J., Wise, L., Berkowitz, R., Wan, C., Rubin, C., Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263 (1988), 9402–9408.
27. [27] Rosen, E.D., Spiegelman, B.M., Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16 (2000), 145–171.
28. [28] Lefterova, M.I., Lazar, M.A., New developments in adipogenesis. Trends Endocrinol Metab 20 (2009), 107–114.
29. [29] Moldes, M., Zuo, Y., Morrison, R.F., Silva, D., Bae-Hang Park, B.H., Liu, J., Farmer, S.R., Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis. Biochem J 376 (2003), 607–613.
30. [30] Trayhurn, P., Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184 (2005), 285–293.
31. [31] Cowherd, R.M., Lyle, R.E., McGehee, R.E. Jr., Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 10 (1999), 3–10.
32. [32] Kersten, S., Seydoux, J., Peters, J.M., Gonzalez, F.J., Desvergne, B., Wahli, W., Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 103 (1999), 1489–1498.
33. [33] Horton, J.D., Shimomura, I., Ikemoto, S., Bashmakov, Y., Hammer, R.E., Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem 278 (2003), 36652–36660.
34. [34] Brown, M.S., Goldstein, J.L., The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997), 331–340.
35. [35] Kim, J.B., Spiegelman, B.M., ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10 (1996), 1096–1107.
36. [36] Mackall, J., Student, A., Polakis, S.E., Lane, M., Induction of lipogenesis during differentiation in a “preadipocyte” cell line. J Biol Chem 251 (1976), 6462–6464.
37. [37] Paulauskis, J.D., Sul, H., Cloning and expression of mouse fatty acid synthase and other specific mRNAs. Developmental and hormonal regulation in 3T3-L1 cells. J Biol Chem 263 (1988), 7049–7054.
38. [38] Spiegelman, B., Frank, M., Green, H., Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem 258 (1983), 10083–10089.
39. [39] Birt, D.F., Hendrich, S., Wang, W., Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90 (2001), 157–177.
40. [40] Shukla, S., Gupta, S., Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther 5 (2006), 843–852.
41. [41] Ono, M., Fujimori, K., Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells. J Agric Food Chem 59 (2011), 13346–13352.
42. [42] Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., Wang, S., Wu, J., Wang, Y., Li, Z., Liu, J., Jiang, J.D., Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10 (2004), 1344–1351.
43. [43] Huang, C., Zhang, Y., Gong, Z., Sheng, X., Li, Z., Zhang, W., Qin, Y., Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway. Biochem Biophys Res Commun 348 (2006), 571–578.
44. [44] Lee, Y.S., Kim, W.S., Kim, K.H., Yoon, M.J., Cho, H.J., Shen, Y., Ye, J.M., Lee, C.H., Oh, W.K., Kim, C.T., Hohnen-Behrens, C., Gosby, A., Kraegen, E.W., James, D.E., Kim, J.B., Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55 (2006), 2256–2264.
45. [45] Cordell, G.A., Araujo, O.E., Capsaicin: identification, nomenclature, and pharmacotherapy. Ann Pharmacother 27 (1993), 330–336.
46. [46] Hsu, C.L., Yen, G.C., Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. J Agric Food Chem 55 (2007), 1730–1736.
47. [47] Hwang, J.T., Park, I.J., Shin, J.I., Lee, Y.K., Lee, S.K., Baik, H.W., Ha, J., Park, O.J., Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338 (2005), 694–699.
48. [48] Naef, R., Jaquier, A., Velluz, A., Maurer, B., New constituents related to 3-methyl-2, 4-nonanedione identified in green tea. J Agric Food Chem 54 (2006), 9201–9205.
49. [49] Moon, H.S., Chung, C.S., Lee, H.G., Kim, T.G., Choi, Y.J., Cho, C.S., Inhibitory effect of (−)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells. Obesity (Silver Spring) 15 (2007), 2571–2582.
50. [50] Chan, C.Y., Wei, L., Castro-Muñozledo, F., Koo, W.L., (−)-Epigallocatechin-3-gallate blocks 3T3-L1 adipose conversion by inhibition of cell proliferation and suppression of adipose phenotype expression. Life Sci 89 (2011), 779–785.
51. [51] Lee, H., Bae, S., Yoon, Y., The anti-adipogenic effects of (-) epigallocatechin gallate are dependent on the WNT/β-catenin pathway. J Nutr Biochem 24 (2013), 1232–1240.
52. [52] Harmon, A.W., Patel, Y.M., Genistein inhibits CCAAT/enhancer-binding protein β (C/EBPβ) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J 367 (2002), 203–208.
53. [53] Huang, J.P., Huang, S.S., Deng, J.Y., Chang, C.C., Day, Y.J., Hung, L.M., Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin. Free Radic Biol Med 49 (2010), 1710–1721.
54. [54] Rayalam, S., Yang, J.Y., Ambati, S., Della-Fera, M.A., Baile, C.A., Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 22 (2008), 1367–1371.
55. [55] Chang, C.C., Lin, K.Y., Peng, K.Y., Day, Y.J., Hung, L.M., Resveratrol exerts anti-obesity effects in high-fat diet obese mice and displays differential dosage effects on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cells. Endocr J 63 (2016), 169–178.
56. [56] Li, H., Cheng, K.W., Cho, C.-H., He, Z., Wang, M., Oxyresveratrol as an antibrowning agent for cloudy apple juices and fresh-cut apples. J Agric Food Chem 55 (2007), 2604–2610.
57. [57] Tan, H.Y., Iris, M., Li, E.T., Wang, M., Inhibitory effects of oxyresveratrol and cyanomaclurin on adipogenesis of 3T3-L1 cells. J Funct Foods 15 (2015), 207–216.
58. [58] Ammon, H.P., Wahl, M.A., Pharmacology of Curcuma longa. Planta Med 57 (1991), 1–7.
59. [59] Ahn, J., Lee, H., Kim, S., Ha, T., Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling. Am J Physiol Cell Physiol 298 (2010), C1510–C1516.
60. [60] Kim, C.Y., Le, T.T., Chen, C., Cheng, J.X., Kim, K.H., Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J Nutr Biochem 22 (2011), 910–920.
61. [61] Ferguson, B.S., Nam, H., Morrison, R.F., Curcumin inhibits 3T3-L1 preadipocyte proliferation by mechanisms involving post-transcriptional p27 regulation. Biochem Biophys Rep 5 (2016), 16–21.
62. [62] Gordon, O.N., Luis, P.B., Ashley, R.E., Osheroff, N., Schneider, C., Oxidative transformation of demethoxy-and bisdemethoxycurcumin: products, mechanism of formation, and poisoning of human topoisomerase IIα. Chem Res Toxicol 28 (2015), 989–996.
63. [63] Lai, C.S., Chen, Y.Y., Lee, P.S., Kalyanam, N., Ho, C.T., Liou, W.S., Yu, R.C., Pan, M.H., Bisdemethoxycurcumin inhibits adipogenesis in 3T3-L1 preadipocytes and suppresses obesity in high-fat diet-fed C57BL/6 mice. J Agric Food Chem 64 (2016), 821–830.
64. [64] Armanini, D., Nacamulli, D., Francini-Pesenti, F., Battagin, G., Ragazzi, E., Fiore, C., Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroids 70 (2005), 538–542.
65. [65] Moon, M.H., Jeong, J.K., Lee, Y.J., Seol, J.W., Ahn, D.C., Kim, I.S., Park, S.Y., 18β-Glycyrrhetinic acid inhibits adipogenic differentiation and stimulates lipolysis. Biochem Biophys Res Commun 420 (2012), 805–810.
66. [66] Yeh, K.Y., Shou, S.S., Lin, Y.X., Chen, C.C., Chiang, C.Y., Yeh, C.Y., Effect of Ginkgo Biloba extract on lipopolysaccharide-induced anhedonic depressive-like behavior in male rats. Phytother Res 29 (2015), 260–266.
67. [67] Liou, C.J., Lai, X.Y., Chen, Y.L., Wang, C.L., Wei, C.-H., Huang, W.C., Ginkgolide C suppresses adipogenesis in 3T3-L1 adipocytes via the AMPK signaling pathway. Evid Based Complement Alternat Med, 2015, 2015, 298635.
68. [68] Tao, X., Younger, J., Fan, F.Z., Wang, B., Lipsky, P.E., Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum 46 (2002), 1735–1743.
69. [69] Choi, S.K., Park, S., Jang, S., Cho, H.H., Lee, S., You, S., Kim, S.H., Moon, H.S., Cascade regulation of PPARγ 2 and C/EBPα signaling pathways by celastrol impairs adipocyte differentiation and stimulates lipolysis in 3T3-L1 adipocytes. Metabolism 65 (2016), 646–654.
70. [70] Rayalam, S., Della-Fera, M.A., Baile, C.A., Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 19 (2008), 717–726.
71. [71] Mittendorfer, B., Magkos, F., Fabbrini, E., Mohammed, B.S., Klein, S., Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) 17 (2009), 1872–1877.
72. [72] Saponaro, C., Gaggini, M., Carli, F., Gastaldelli, A., The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7 (2015), 9453–9474.
73. [73] Greenberg, A.S., Shen, W.-J., Muliro, K., Patel, S., Souza, S.C., Roth, R.A., Kraemer, F.B., Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem 276 (2001), 45456–45461.
74. [74] Horton, M., Scrimgeour, P., Rawn. Principles of biochemistry. 4th ed., 2006, Prentice Hall, Toronto.
75. [75] Rupasinghe, H.V., Sekhon-Loodu, S., Mantso, T., Panayiotidis, M.I., Phytochemicals in regulating fatty acid β-oxidation: potential underlying mechanisms and their involvement in obesity and weight loss. Pharmacol Ther 165 (2016), 153–163.
76. [76] Lee, M.S., Kim, C.T., Kim, I.H., Kim, Y., Effects of capsaicin on lipid catabolism in 3T3-L1 adipocytes. Phytother Res 25 (2011), 935–939.
77. [77] Lee, M.S., Kim, C.T., Kim, I.H., Kim, Y., Inhibitory effects of green tea catechin on the lipid accumulation in 3T3-L1 adipocytes. Phytother Res 23 (2009), 1088–1091.
78. [78] Ejaz, A., Wu, D., Kwan, P., Meydani, M., Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139 (2009), 919–925.
79. [79] Lone, J., Choi, J.H., Kim, S.W., Yun, J.W., Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes. J Nutr Biochem 27 (2016), 193–202.
80. [80] Choi, J.H., Yun, J.W., Chrysin induces brown fat–like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes. Nutrition 32 (2016), 1002–1010.
81. [81] Choi, J.H., Kim, S.W., Yu, R., Yun, J.W., Monoterpene phenolic compound thymol promotes browning of 3T3-L1 adipocytes. Eur J Nutr, 2016, 10.1007/s00394-016-1273-2.
82. [82] Rosen, E.D., Spiegelman, B.M., What we talk about when we talk about fat. Cell 156 (2014), 20–44.
83. [83] Lazar, M.A., How now, brown fat?. Science 321 (2008), 1048–1049.
84. [84] Parray, H.A., Yun, J.W., Cannabidiol promotes browning in 3T3-L1 adipocytes. Mol Cell Biochem 416 (2016), 131–139.
85. [85] Cypess, A.M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A.B., Kuo, F.C., Palmer, E.L., Tseng, Y.H., Doris, A., Kolodny, G.M., Kahn, R., Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360 (2009), 1509–1517.
86. [86] Virtanen, K.A., Lidell, M.E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.J., Enerbäck, S., Nuutila, P., Functional brown adipose tissue in healthy adults. N Engl J Med 360 (2009), 1518–1525.
87. [87] Klingenspor, M., Herzig, S., Pfeifer, A., Brown fat develops a brite future. Obes Facts 5 (2012), 890–896.
88. [88] Bartelt, A., Heeren, J., Adipose tissue browning and metabolic health. Nature Rev Endocrinol 10 (2014), 24–36.
89. [89] Ricquier, D., Uncoupling protein 1 of brown adipocytes, the only uncoupler: a historical perspective. Front Endocrinol (Lausanne), 2, 2011, 85.
90. [90] Vitali, A., Murano, I., Zingaretti, M.C., Frontini, A., Ricquier, D., Cinti, S., The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J Lipid Res 53 (2012), 619–629.
91. [91] Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M., Spiegelman, B.M., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 (1998), 829–839.
92. [92] Bonet, M.L., Oliver, P., Palou, A., Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim Biophys Acta 1831 (2013), 969–985.
93. [93] Petrovic, N., Walden, T.B., Shabalina, I.G., Timmons, J.A., Cannon, B., Nedergaard, J., Chronic peroxisome proliferator-activated receptor γ (PPARγ) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 285 (2010), 7153–7164.
94. [94] Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H.M., Erdjument-Bromage, H., Tempst, P., Rudnicki, M.A., Beier, D.R., Spiegelman, B.M., PRDM16 controls a brown fat/skeletal muscle switch. Nature 454 (2008), 961–967.
95. [95] Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L.M., Uldry, M., Tavernier, G., Langin, D., Spiegelman, B.M., Transcriptional control of brown fat determination by PRDM16. Cell Metab 6 (2007), 38–54.
96. [96] Hondares, E., Rosell, M., Díaz-Delfín, J., Olmos, Y., Monsalve, M., Iglesias, R., Villarroya, F., Giralt, M., Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat involvement of PRDM16. J Biol Chem 286 (2011), 43112–43122.
97. [97] Kajimura, S., Seale, P., Kubota, K., Lunsford, E., Frangioni, J.V., Gygi, S.P., Spiegelman, B.M., Initiation of myoblast to brown fat switch by a PRDM16–C/EBP- beta transcriptional complex. Nature 460 (2009), 1154–1158.
98. [98] Wu, J., Boström, P., Sparks, L.M., Ye, L., Choi, J.H., Giang, A.H., Khandekar, M., Virtanen, K.A., Nuutila, P., Schaart, G., Huang, K., Tu, H., van Marken Lichtenbelt, W.D., Hoeks, J., Enerbäck, S., Schrauwen, P., Spiegelman, B.M., Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150 (2012), 366–376.
99. [99] Sharp, L.Z., Shinoda, K., Ohno, H., Scheel, D.W., Tomoda, E., Ruiz, L., Hu, H., Wang, L., Pavlova, Z., Gilsanz, V., Kajimura, S., Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS One, 7, 2012, e49452.
100. [100] Lidell, M.E., Betz, M.J., Leinhard, O.D., Heglind, M., Elander, L., Slawik, M., Mussack, T., Nilsson, D., Romu, T., Nuutila, P., Virtanen, K.A., Beuschlein, F., Persson, A., Borga, M., Enerbäck, S., Evidence for two types of brown adipose tissue in humans. Nat Med 19 (2013), 631–634.
101. [101] Martinez de Mena, R., Scanlan, T.S., Obregon, M.J., The T3 receptor β1 isoform regulates UCP1 and D2 deiodinase in rat brown adipocytes. Endocrinology 151 (2010), 5074–5083.
102. [102] Ohno, H., Shinoda, K., Spiegelman, B.M., Kajimura, S., PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 15 (2012), 395–404.
103. [103] Asano, H., Kanamori, Y., Higurashi, S., Nara, T., Kato, K., Matsui, T., Funaba, M., Induction of beige-like adipocytes in 3T3-L1 cells. J Vet Med Sci 76 (2014), 57–64.